Tag
Dr. Reddy's Laboratories Limited
2 articles
Dr. Reddy's Semaglutide API Impurity Halts Supply
Dr. Reddy's disclosed a manufacturing impurity in scaled-up Semaglutide API batches, halting commercial supply for approximately three months.
The company expects a potential inventory write-down and
Dr. Reddy's Q1 Conference Call Audio Recording
Dr. Reddy's Laboratories disclosed the audio recording of its investor conference call held on July 9, 2026.
The disclosure was made pursuant to SEBI Listing Regulations (Regulation 30) for informatio